Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Childhood Cancer Predisposition Study (CCPS)

for
Pediatric Cancer
Location: Boston MA, Philadelphia PA, Toronto, Atlanta GA,
Sponsor: Emory University

Sex: All

Age: 0+

Code: NCT04511806

Recruiting

Cardiometabolic Screening Program

for
Breast Cancer, Early-stage Breast Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT05386719

Recruiting

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

for
Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma
Location: Port Saint Lucie FL, Huntersville NC, Greenville SC,
Sponsor: FBD Biologics Limited

Sex: All

Age: 18+

Code: NCT05892718

Phase 1, Recruiting

Lorlatinib Combinations in Lung Cancer

for
Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04292119

Phase 1, Phase 2, Recruiting

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

for
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Location: Boston MA, Hollywood FL, Athens GA, Columbus OH,
Sponsor: Turning Point Therapeutics, Inc.

Sex: All

Age: 12+

Code: NCT03093116

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

for
Refractory and/or Relapsed Metastatic Solid Tumors
Location: Valhalla NY, The Bronx NY, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 1 - 50

Code: NCT01804634

Phase 2, Recruiting

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Boston MA, Buffalo NY, Irvine CA, Duarte CA,
Sponsor: City of Hope Medical Center

Sex: All

Age: 70+

Code: NCT04305834

Phase 2, Recruiting

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

for
Bladder Cancer, Urinary Bladder Neoplasm, Urologic Neoplasms,
Location: Boston MA, Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18+

Code: NCT04442724

Recruiting

Expressive Writing for the Management of Stress in Cancer Survivors

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04776941

Recruiting

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

for
Endometrial Cancer, Endometrioid Tumor, Cancer, Tumor,
Location: Providence RI, New York NY, Miami Beach FL,
Sponsor: Aadi Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT05997017

Phase 2, Recruiting

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

for
Breast Cancer, Ovarian Cancer
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: Female

Age: 21+

Code: NCT06430541

Phase 1, Recruiting

Statins and Breast Cancer Biomarkers

for
Breast Cancer
Location: Boston MA, Burlington VT, Newark DE, Goldsboro NC,
Sponsor: University of Vermont

Sex: Female

Age: 35 - 55

Code: NCT00914017

Phase 2, Recruiting

A Multi-Institutional Registry for CyberKnife Stereotactic Accelerated Partial Breast Irradiation (CK-SAPBI)

for
Breast Cancer
Location: Washington DC
Sponsor: Georgetown University

Sex: Female

Age: 50 - 70+

Code: NCT02457117

Recruiting

Wisconsin Ginseng for Decreasing Cancer Related Fatigue

for
Malignant Solid Neoplasm, Chronic Lymphocytic Leukemia,
Location: Duluth MN, Virginia MN, Rochester MN, Hibbing MN,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06395441

Phase 3, Recruiting

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

for
Clear Cell Renal Cell Carcinoma, Solid Tumors
Location: Boston MA, New York NY, Baltimore MD, Miami FL,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05536141

Phase 1, Recruiting

Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer

for
HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer
Location: Hershey PA, Miami FL, Cleveland OH, Ypsilanti MI,
Sponsor: SynDevRx, Inc.

Sex: All

Age: 18+

Code: NCT05455619

Phase 1, Phase 2, Recruiting

000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

for
Brain Tumor, Cancer
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 15 - 70+

Code: NCT05588141

Phase 1, Phase 2, Recruiting

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

for
Colitis, Diarrhea, Malignant Genitourinary System Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04038619

Phase 1, Recruiting

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

for
Pediatric Cancer
Location: Charlotte NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 2 - 21

Code: NCT04948619

Phase 2, Recruiting

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

for
Metastatic Breast Cancer, Leptomeningeal Disease
Location: Baltimore MD, Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT02422641

Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial